Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography

This publication has 17 references indexed in Scilit:

• Positron Emission Tomography Using [¹⁸F]-Fluorodeoxy-d-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
  Journal of Clinical Oncology, 2000
• Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
  Journal of Clinical Oncology, 1998
• Gamma emission imaging in the management of breast disorders
  European Journal of Surgical Oncology, 1998
• Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer
  British Journal of Cancer, 1998
• Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy
  The American Journal of Surgery, 1998
• Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer.
  Journal of Ultrasound in Medicine, 1997
• Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
  Journal of Clinical Oncology, 1997
• Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer
  British Journal of Cancer, 1996
• Positron emission tomography: 2-deoxy-2-Z18F]-fluoro-d-glucose uptake in locally advanced breast cancers
  European Journal of Surgical Oncology, 1995
• Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.
  Radiology, 1991